Published in Immunotherapy Weekly, June 11th, 2003
Centocor, Inc., is supporting FOCIS' initiative through an unrestricted educational grant. Centocor recognized the centers receiving the grants at the FOCIS annual meeting in Paris, France. FOCIS has been successful in aligning several partners in addition to Centocor in their efforts; additional significant sponsors are expected to join this initiative over the next several years.
FOCIS centers are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.